Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-14

Clinical Trial Update: Effect of CSII and CGM on Progression of Late Diabetic Complications [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether insulin pump therapy (CSII) combined with continuous glucose monitoring (CGM) affects the progression of late diabetic complic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Continuous glucose monitor
  • Insulin pump

Snippet

Sponsor: Steen Andersen | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED